Literature DB >> 15107310

Sex and age differences in lipoprotein subclasses measured by nuclear magnetic resonance spectroscopy: the Framingham Study.

David S Freedman1, James D Otvos, Elias J Jeyarajah, Irina Shalaurova, L Adrienne Cupples, Helen Parise, Ralph B D'Agostino, Peter W F Wilson, Ernst J Schaefer.   

Abstract

BACKGROUND: The sex differential in coronary heart disease (CHD) risk, which is not explained by male/female differences in lipid and lipoprotein concentrations, narrows with age. We examined whether this differential CHD risk might, in part, be attributable to the sizes of lipoprotein particles or concentrations of lipoprotein subclasses.
METHODS: We analyzed frozen plasma samples from 1574 men and 1692 women from exam cycle 4 (1988-1990) of the Framingham Offspring Study. Nuclear magnetic resonance (NMR) spectroscopy was used to determine the subclass concentrations and mean sizes of VLDL, LDL, and HDL particles. Concentrations of lipids and apolipoproteins were measured by standard chemical methods.
RESULTS: In addition to the expected sex differences in concentrations of triglycerides, LDL-cholesterol, and HDL-cholesterol, women also had a lower-risk subclass profile consisting of larger LDL (0.4 nm) and HDL (0.5 nm) particles. The sex difference was most pronounced for HDL, with women having a twofold higher (8 vs 4 micromol/L) concentration of large HDL particles than men. Furthermore, similar to the narrowing of the sex difference in CHD risk with age, the observed male/female difference in HDL particle size also decreased with age. Although lipoprotein particle sizes were highly correlated with lipid and lipoprotein concentrations, the sex differences in the mean sizes of lipoprotein particles persisted (P <0.001) even after adjustment for lipid and lipoprotein concentrations.
CONCLUSIONS: Women have a less atherogenic subclass profile than men, even after accounting for differences in lipid concentrations.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15107310     DOI: 10.1373/clinchem.2004.032763

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  84 in total

1.  HDL proteomics: pot of gold or Pandora's box?

Authors:  Muredach P Reilly; Alan R Tall
Journal:  J Clin Invest       Date:  2007-03       Impact factor: 14.808

2.  1H NMR spectroscopy quantifies visibility of lipoproteins, subclasses, and lipids at varied temperatures and pressures.

Authors:  Daniela Baumstark; Werner Kremer; Alfred Boettcher; Christina Schreier; Paul Sander; Gerd Schmitz; Renate Kirchhoefer; Fritz Huber; Hans Robert Kalbitzer
Journal:  J Lipid Res       Date:  2019-06-25       Impact factor: 5.922

3.  Sex Differences in Blood HDL-c, the Total Cholesterol/HDL-c Ratio, and Palmitoleic Acid are Not Associated with Variants in Common Candidate Genes.

Authors:  Shannon L Klingel; Kaitlin Roke; Bertha Hidalgo; Stella Aslibekyan; Robert J Straka; Ping An; Michael A Province; Paul N Hopkins; Donna K Arnett; Jose M Ordovas; Chao-Qiang Lai; David M Mutch
Journal:  Lipids       Date:  2017-10-27       Impact factor: 1.880

4.  Reduced growth hormone secretion in obesity is associated with smaller LDL and HDL particle size.

Authors:  Hideo Makimura; Meghan N Feldpausch; Takara L Stanley; Noelle Sun; Steven K Grinspoon
Journal:  Clin Endocrinol (Oxf)       Date:  2012-02       Impact factor: 3.478

5.  The Associations of Indices of Obesity with Lipoprotein Subfractions in Japanese American, African American and Korean Men.

Authors:  Nobutaka Hirooka; Chol Shin; Kamal H Masaki; Daniel Edmundowicz; Jina Choo; Emma J M Barinas-Mitchell; Bradley J Willcox; Kim Sutton-Tyrrell; Aiman El-Saed; Iva Miljkovic-Gacic; Takayoshi Ohkubo; Katsuyuki Miura; Hirotsugu Ueshima; Lewis H Kuller; Akira Sekikawa
Journal:  Glob Heart       Date:  2013-09-01

6.  Sex differences in the associations of visceral adiposity, homeostatic model assessment of insulin resistance, and body mass index with lipoprotein subclass analysis in obese adolescents.

Authors:  Jacquelyn A Hatch-Stein; Andrea Kelly; Samuel S Gidding; Babette S Zemel; Sheela N Magge
Journal:  J Clin Lipidol       Date:  2016-02-16       Impact factor: 4.766

7.  Are changes in cardiovascular disease risk factors in midlife women due to chronological aging or to the menopausal transition?

Authors:  Karen A Matthews; Sybil L Crawford; Claudia U Chae; Susan A Everson-Rose; Mary Fran Sowers; Barbara Sternfeld; Kim Sutton-Tyrrell
Journal:  J Am Coll Cardiol       Date:  2009-12-15       Impact factor: 24.094

8.  Evaluation of a community-based participatory physical activity promotion project: effect on cardiovascular disease risk profiles of school employees.

Authors:  Noha H Farag; William E Moore; David M Thompson; Cee E Kobza; Kathryn Abbott; June E Eichner
Journal:  BMC Public Health       Date:  2010-06-05       Impact factor: 3.295

9.  Loss-of-function variants in endothelial lipase are a cause of elevated HDL cholesterol in humans.

Authors:  Andrew C Edmondson; Robert J Brown; Sekar Kathiresan; L Adrienne Cupples; Serkalem Demissie; Alisa Knodle Manning; Majken K Jensen; Eric B Rimm; Jian Wang; Amrith Rodrigues; Vaneeta Bamba; Sumeet A Khetarpal; Megan L Wolfe; Stephanie Derohannessian; Mingyao Li; Muredach P Reilly; Jens Aberle; David Evans; Robert A Hegele; Daniel J Rader
Journal:  J Clin Invest       Date:  2009-03-16       Impact factor: 14.808

10.  A novel approach for measuring sphingosine-1-phosphate and lysophosphatidic acid binding to carrier proteins using monoclonal antibodies and the Kinetic Exclusion Assay.

Authors:  Jonathan K Fleming; Thomas R Glass; Steve J Lackie; Jonathan M Wojciak
Journal:  J Lipid Res       Date:  2016-07-21       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.